- Ability to understand and the willingness to sign a written informed consent
document.

Exclusion Criteria:

- Patients who have had previous chemotherapy or radiotherapy for the treatment of CLL.

- Patients may not be receiving any other investigational agents.

- Patients with known brain involvement should be excluded from this clinical trial
because of their poor prognosis and because they often develop progressive neurologic
dysfunction that would confound the evaluation of neurologic and other adverse
events.

- History of allergic reactions attributed to compounds of similar chemical or biologic
composition to bendamustine or rituximab.

Name

Location

We are a Cancer Social Network, Resource Directory & Education Hub supporting all those affected by cancer. knowcancer.com is intended to be solely for informational purposes and should not be a substitute for professional medical advice, diagnosis or treatment.